Important: Therapy
Antibiotic therapy should be avoided due to increased risk of HUS in potential Shigatoxin-producing E.coli (e.g. 0157) infection and risk of exacerbating potential C. difficile infection
We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. When you install the update, you will see that each toolkit has a small QR code icon the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.
You may need to actively install the update to install RDS app version 4.7.1 to see this improvement. Installing this update is also strongly recommended to get the full benefits of the new contingency arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits.
To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. To install latest updates:
On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.
On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.
Please get in touch with ann.wales3@nhs.scot with any questions.
Most infections will be self-limiting in nature.
Even bacterial infections e.g. Campylobacter, Salmonella are commonly self-limiting.
Send stool sample for culture. If bacterial pathogen identified, report will contain comment to guide management.
If C. difficile infection is strongly suspected - review C difficile Infection (CDI) guidance and consider empirical management.
Antibiotic therapy should be avoided due to increased risk of HUS in potential Shigatoxin-producing E.coli (e.g. 0157) infection and risk of exacerbating potential C. difficile infection
Gentamicin as per protocol
AND
Amoxicillin 1g IV 8 hourly (or Vancomycin IV as per protocol if penicillin allergy)
AND
Metronidazole 400mg PO 8 hourly or 500mg IV 8 hourly
Treatment duration: 5 days
Oral switch guidance
Review culture results first. If no positive microbiology to guide:
Preferred regime - Co-amoxiclav 625mg PO 8 hourly
Alternative - Co-trimoxazole 960mg PO 12 hourly AND Metronidazole 400mg 8 hourly
Review need for antibiotics daily including any available microbiology results.